Navigation Links
Canada launches first gene therapy trial for Fabry disease
Date:1/24/2013

l Centre in Calgary has specialized expertise in the stem cell filtering process that will be used for the clinical trial.

"The trigger that's making all this possible is Calgary's expertise in isolating the specific blood stem cells we need," says Dr. Medin. "Without a sufficient quantity of those stem cells to work with, our likelihood of success would be greatly reduced."

In the Fabry trial, technologists led by Dr. Nicole Prokopishyn, director of the Calgary Laboratory Services Cellular Therapy Lab, processed the blood from a donor patient and isolated a specific type of stem cell called a CD34+ cell.

Christopher Armstrong, a 34-year-old Calgarian with Fabry disease, recently donated his blood for key initial experiments for the first phase of the trial. Nearly a billion of Christopher's CD34+ cells have been isolated and will be sent to Dr. Medin's lab in Toronto. Dr. Medin's team will take those cells and, using a modified virus, insert a working copy of the GLA gene into the stem cells.

"We use a type of virus called a lentivirus, which has been modified in a couple of critical ways," says Dr. Medin, who is also a professor in the Department of Medical Biophysics at the University of Toronto. "First, it's been stripped of any of its disease-causing capability and is safe. Second, it has the corrected functional GLA gene, which will cause the donor cells to make the correct enzyme. When the corrected cells circulate in the blood, they also secrete the enzyme, which is then taken up by unmodified cells. This effectively extends the therapy afforded by the modified stem cells."

The corrected cells go back into the donor patient, meaning there is less likelihood for rejection compared to cells coming from a different individual.

Like many other Fabry patients, Armstrong is currently on Enzyme Replacement Therapy (ERT), which requires a home care nurse to come to his house every two weeks to administer an
'/>"/>

Contact: Gregory Harris
gregory.harris@albertahealthservices.ca
403-619-3108
Alberta Health Services
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Disease-carrying colonizers on the move: Predicting the spread of ticks across Canada
2. Ducks Unlimited Canada and Canadian Light Source partnership to shed light on wetlands
3. Potent human toxins prevalent in Canadas freshwaters
4. Meet Xenoceratops: Canadas newest horned dinosaur
5. USAs ancient hurricane belt and the US-Canada equator
6. Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries
7. LABS, Inc. Launches Suite of Next-Generation Test Offerings; Focuses on Expanding Complex Biologic Testing Portfolio in 2012
8. Elsevier launches new journal Algal Research
9. Clinical trial launches to see whether vitamin D helps treat multiple sclerosis
10. Thomson Reuters Launches Life Sciences Partner Ecosystem to Drive Collaborative R&D Drug Processes
11. WanderID Launches Breakthrough ID Product for Children, Seniors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... 23, 2015, after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
(Date:4/2/2015)... 2015 At its 2015 ACMG Annual Clinical ... , the American College of Medical Genetics and Genomics ... its Board.  Members of the ACMG Board of Directors ... and advancing its policies and programs. ACMG is the ... "It,s an eventful time in medical genetics and genomics.  ...
(Date:4/1/2015)...   Medisafe ™, the leading global medication management ... and Android smartphones and tablets, announces ... platform to allow patients to track and correlate their ... patients will be able to visualize in real-time how ... such as glucose levels and blood pressure. ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
... time in 11 years, USC Associate Professor Ellis Meng ... the classroom not answering them. Meng, whose ... medication-delivery system, is enrolled in a business crash-course sponsored ... customers, develop viable business models, and get on the ...
... with endless color, but physiologically the human eye sees only ... a Tel Aviv University-developed technology is using colors invisible to ... With the ability to detect more than 1,000 colors, the ... used to "diagnose" contaminants and other environmental hazards in real ...
... Ga. Examining the chin and upper and lower abdomen ... hair growth in women, a key indicator of too much ... way to identify this problem in women that was as ... endocrinologist and President of Georgia Health Sciences University. ...
Cached Biology News:USC scientist's revolutionary drug pump draws NSF support 2Thousand-color sensor reveals contaminants in Earth and sea 2Women's chin, abdomen are good indicators of excessive hair growth 2Women's chin, abdomen are good indicators of excessive hair growth 3
(Date:5/5/2015)... , May 5, 2015  Tikcro Technologies Ltd. ... approved to continue trading on OTCQB  Marketplace, the ... OTCQB Marketplace allows for a continuous public market ... can have real-time quotes and market information on ... The OTCQB Marketplace includes U.S. and international companies ...
(Date:5/5/2015)... NEW YORK , May 5, 2015 /PRNewswire/ ... today announced that Andrew Gengos , President and ... on May 7, 2015. DATE:  Thursday, May ... LINK:  http://VirtualInvestorConferences.com > click the ... will be a live, interactive online event where ...
(Date:5/5/2015)... May 05, 2015 Research and Markets ... of the "Clinical Laboratory, Molecular Diagnostics and ... to 2019 - Global Version" report to ... in the area of molecular diagnostics and pharmacogenics ... evolving world market that is moving out of ...
(Date:5/5/2015)... 2015   Tocagen Inc. , a clinical-stage ... Parkinson , M.D., a venture partner at New ... board of directors of Tocagen. Dr. Parkinson has ... clinical development, including leading clinical activities at Amgen ... the cancer therapeutics Gleevec®, Femara®, Zometa®, Kepivance® and ...
Breaking Biology Technology:Tikcro Technologies Announces Approval to Continue Trading on OTCQB 2ImmunoCellular Therapeutics to Webcast Live at VirtualInvestorConferences.com on May 7 2Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4
... Inc have successfully implemented Amphora,s PatentSafe solution to ... PatentSafe as a fully electronic lab notebook, with ... efficiently into today,s laboratories but it also allows ... and effectively, saving significant time previously spent on ...
... Sky One,Medical, Inc. ("China Sky One Medical" or "the ... pharmaceutical company producing over-the-counter,drugs in the People,s Republic of ... quarter and fiscal year ended December 31,2008. , , ... -- Total revenues increased 104.0% year-over-year to $26.0 ...
... Hovione is pleased to announce,that its licensee Daiichi ... use Hovione,s TwinCaps(R) dry powder inhaler device in ... neuraminidase inhibitor active,against the influenza virus. Daiichi Sankyo ... in Japan and other Asian countries and results,are ...
Cached Biology Technology:Solidus Bioscience Protect their Research and Improve Efficiency With Amphora's PatentSafe Solution 2Solidus Bioscience Protect their Research and Improve Efficiency With Amphora's PatentSafe Solution 3China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 2China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 3China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 4China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 5China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 6China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 7China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 8China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 9China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 10Hovione's TwinCaps(R) Inhaler in Phase III Clinical Trials for Influenza 2Hovione's TwinCaps(R) Inhaler in Phase III Clinical Trials for Influenza 3
... anti-phospho-IRS1 (Tyr896) ... to amino acid region encompassing ... phospho-IRS1 (Tyr896). ... Quality Assurance: ...
Goat polyclonal to PPP2R5D Immunogen: Peptide with sequence KRAEEFLTASQEAL, from C Terminus of the protein sequence according to NP_006236...
...
Monoclonal Mouse Anti-Human Cytokeratin 16 (48 kD)...
Biology Products: